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Claspin is essential for the ATR-dependent activation
of Chk1 in Xenopus egg extracts containing incom-
pletely replicated or UV-damaged DNA. The activated
form of Claspin contains two repeated phosphopeptide
motifs that mediate its binding to Chk1. We show that
these phosphopeptide motifs bind to Chk1 by means of
its N-terminal kinase domain. The binding site on Chk1
involves a positively charged cluster of amino acids that
contains lysine 54, arginine 129, threonine 153, and ar-
ginine 162. Mutagenesis of these residues strongly com-
promises the ability of Chk1 to interact with Claspin.
These amino acids lie within regions of Chk1 that are
involved in various aspects of its catalytic function. The
predicted position on Chk1 of the phosphate group from
Claspin corresponds to the location of activation-loop
phosphorylation in various kinases. In addition, we
have obtained evidence that the C-terminal regulatory
domain of Chk1, which does not form a stable complex
with Claspin under our assay conditions, nonetheless
has some role in Claspin-dependent activation. Overall,
these results indicate that Claspin docks with a phos-
phate-binding site in the catalytic domain of Chk1 dur-
ing activation by ATR. Phosphorylated Claspin may
mimic an activating phosphorylation of Chk1 during
this process.
Eukaryotic cells utilize checkpoint control mechanisms to
preserve the integrity of their genomes (1, 2). For example, cells
prevent the initiation of mitosis if DNA replication has not
occurred normally. In vertebrates, this control system, which is
known as the DNA replication checkpoint, employs the effector
kinase Chk1 to suppress activation of the Cdc2-cyclin B com-
plex, a critical regulator of the G2/M transition (3). In particu-
lar, Chk1 down-regulates the phosphatase Cdc25 and up-reg-
ulates the kinase Wee1, which together control inhibitory
phosphorylation of Cdc2 on tyrosine residue 15 (1). The activa-
tion of Chk1 in response to checkpoint-inducing signals in the
genome is dependent on ATR, a protein kinase in the family
that also includes ATM and DNA-PK (4–7).
We have been using Xenopus egg extracts to study how
vertebrate cells monitor the presence of incompletely replicated
DNA during the cell cycle. In this system, Xenopus Chk1
(Xchk1)1 undergoes phosphorylation and activation in response
to DNA replication inhibitors such as aphidicolin (8). Certain
synthetic oligonucleotides also elicit the efficient activation of
Xchk1 (9). The activation of Xchk1 requires phosphorylation on
conserved Ser-Gln/Thr-Gln (SQ/TQ) motifs in its C-terminal
domain by the Xenopus homologue of ATR (Xatr) (4, 5).
The Xatr-dependent phosphorylation and activation of
Xchk1 depends upon Claspin, a large acidic protein that binds
to Xchk1 during a checkpoint response (9). Homologues of
Claspin called Mrc1 were identified subsequently in budding
and fission yeast as regulators of the checkpoint effector ki-
nases Rad53 and Cds1, respectively (10, 11). Likewise, Claspin
shares functional properties with budding yeast Rad9 and fis-
sion yeast Crb2, which control the activation of Rad53 and
Chk1, respectively (1). Claspin is also found in human cells,
where it likewise functions as a critical component of the DNA
replication checkpoint (9, 12). In recent studies, it was shown
that Claspin interacts with chromatin in a highly regulated
manner during S-phase (13). The chromatin binding properties
of Claspin suggest that it acts as a checkpoint sensor protein
that detects the presence of active DNA replication complexes
in the nuclei of vertebrate cells (13). Mrc1 may fulfill a similar
function in the yeast systems (14).
In previous structure-function studies, we identified proper-
ties of Claspin that allow it to interact with Xchk1 (15). Claspin
contains a 57-amino acid segment, the Chk1-binding domain
(CKBD), which is both necessary and sufficient for this inter-
action. The CKBD contains two repeated Chk1-binding (CKB)
motifs that are approximately 10 amino acids in length. A
serine residue in the center of each motif (Ser-864 and Ser-895)
undergoes phosphorylation during a DNA replication check-
point response. Phosphorylation of both Ser-864 and Ser-895 is
necessary for efficient binding of Claspin to Xchk1, and this
phosphorylation-dependent binding is essential for the activa-
tion of Xchk1 by Xatr. On the basis of these observations, we
surmised that Xchk1 might contain a phosphate-binding site
that would allow it to dock with Claspin. In this report, we have
investigated the molecular features of Xchk1 that mediate its
interaction with Claspin.
EXPERIMENTAL PROCEDURES
Production of Recombinant Xchk1 Proteins—A version of pFastBac
encoding Xchk1 with GST and His6 tags at the C-terminal end (Xchk1-
GH) was described previously (9). To prepare the various truncation
mutants of Xchk1-GH that are described in this study, the RsrII-SpeI
fragment of pFastBac-Xchk1-GH was removed by digestion with RsrII
and SpeI. DNA fragments encoding the desired sections of Xchk1 were
amplified by PCR with the appropriate primers containing RsrII or SpeI
sites. These fragments were ligated back into the digested pFastBac-
Xchk1-GH vector. The N135A and 4AQ point mutants of Xchk1-GH
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were described before (9). The T377A and 4AQ/T377A mutants of
Xchk1-GH were produced by swapping the appropriate DNA fragments
from pFastBacHTa-Xchk1-T377A and pFastBacHTa-Xchk1–4AQ/
T377A (16) into pFastBac-Xchk1-GH. The K53A, K54A, R129A, T153A,
and R162A point mutants of Xchk1-GH were produced with the
QuikChange kit (Stratagene). Recombinant baculoviruses were pro-
duced with the Bac-to-Bac system (Invitrogen). Recombinant proteins
were expressed in Sf9 insect cells and purified as described previously
(9). A 35S-labeled fragment of Xchk1 containing amino acids 266–474 as
well as Met and Ala at the N terminus was produced by using the TNT
T7 Quick for PCR DNA kit (Promega) as described previously (15). For
this procedure, the 5 primer contained a T7 promoter sequence.
Preparation of Maltose-binding Protein (MBP)-CKBD—A DNA frag-
ment encoding amino acids 838–920 of Claspin, which contains the
CKBD, was amplified by PCR and cloned into pMAL (New England
Biolabs) that had been digested with SalI and HindIII. MBP-CKBD was
expressed in Codon-Plus (RIL) Escherichia coli cells, isolated with am-
ylose resin (New England Biolabs), and eluted with HEPES-buffered
saline containing 20 mM maltose.
Assay for Binding of Claspin to Xchk1 and Its Fragments—In one
type of assay, recombinant Xchk1-GH and various mutants (1 g)
bound to nickel-agarose beads were added to 100 l of Xenopus egg
interphase extract containing 100 g/ml cycloheximide, 3 M okadaic
acid, and 50 g/ml of an annealed mixture consisting of poly(dA)70 and
poly(dT)70, as indicated. The extracts were incubated for 100 min at
room temperature under constant agitation. After the incubation, the
beads were isolated by centrifugation and washed five times with buffer
A (10 mM HEPES-KOH, pH 7.5, 150 mM NaCl, 2.5 mM EGTA, 20 mM
-glycerol phosphate, and 0.5% Nonidet P-40). Alternatively, soluble
Xchk1-GH and various mutants (1 g) were incubated in egg extracts
under the same conditions. Following the incubation, the extracts were
diluted with 200 l of buffer A and centrifuged through a 1-ml Seph-
adex G-25 column. The eluate was incubated with 10 l of glutathione-
agarose for 30 min at 4 °C. The beads were collected and washed three
times with buffer A. Finally, all samples were subjected to SDS-PAGE.
Miscellaneous—35S-Labeled wild-type Claspin and Claspin-2AG
were produced with the TNT in vitro transcription/translation system
(Promega) as described (15). Kinase assays for the activity of Xchk1
were performed with a GST-Cdc25C peptide as substrate as described
previously (8). Immunoblotting with antibodies against Claspin, GST,
and Ser(P)-344 of Xchk1 was described earlier (9, 13). Anti-MBP anti-
bodies were purchased from New England Biolabs.
RESULTS
Claspin Interacts with the N-terminal Kinase Domain of
Xchk1—In previous studies, we demonstrated that Claspin
binds to a recombinant form of Xchk1 (Xchk1-GH) in Xenopus
egg extracts containing an annealed mixture of poly(dA)70 and
poly(dT)70 (hereafter called pA-pT) and a phosphatase inhibitor
such as tautomycin (9). Subsequently, we have found that
okadaic acid is comparably effective to tautomycin. We have
used this assay to investigate what region of Xchk1 is neces-
sary for binding to Claspin. Initially, we prepared various
C-terminal truncations of Xchk1 (Fig. 1, A and B). We observed
that truncations containing amino acids 1–409 and 1–373 of
Xchk1 showed reduced binding to Claspin in comparison with
full-length Xchk1 (residues 1–474). A more severe truncation
containing amino acids 1–311 consistently bound to Claspin
somewhat more efficiently than the 1–409 and 1–373 frag-
ments. A further shortening of the 1–311 fragment to yield the
minimal kinase domain (residues 1–265) resulted in dimin-
ished binding. Nonetheless, we found that the 1–265 fragment
of Xchk1 bound well to Claspin under various assay conditions.
As a control, we showed that a His6-GST fusion protein alone
could not bind to Claspin under these conditions. These exper-
FIG. 1. Claspin binds to the N-terminal kinase domain of
Xchk1. A, diagram of the various truncation mutants of Xchk1 used in
this study. All polypeptides also contain GST and His6 tags at the
C-terminal end. B, full-length (FL) Xchk1-GH and the indicated frag-
ments of Xchk1 (lanes 1–8) were incubated in egg extracts containing
pA-pT and okadaic acid. His6-GST (HG) was used as a control (lane 9).
The tagged proteins were recovered, and binding of endogenous Claspin
was determined by immunoblotting with anti-Claspin antibodies (top).
Recovery of the tagged Xchk1 proteins was monitored by immunoblot-
ting with anti-GST antibodies (bottom). Lane 10 depicts the initial egg
extract (1 l). C and D, binding of Claspin to the indicated fragments
from the kinase domain of Xchk1 was assessed as described in B.
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iments indicate that Claspin clearly interacts with the kinase
domain of Xchk1 (residues 1–265). Nonetheless, removal of all
or part of the C-terminal regulatory domain of Xchk1 (residues
266–474) reduces the binding of Claspin.
Next, we sought to identify the location in the kinase domain
that interacts with Claspin (Fig. 1, C and D). As one approach,
we prepared a variety of C- and N-terminal truncations of the
kinase domain (residues 1–265). In these experiments, we were
unable to identify any fragment of Xchk1 smaller than the
minimal kinase domain that could interact detectably with
Claspin (Fig. 1, C and D). These results indicate that Xchk1
most probably must possess an intact and properly folded ki-
nase domain to associate with Claspin.
Interaction of Claspin with the Kinase Domain of Xchk1
Involves the CKBD—In parallel, we asked whether the binding
of Claspin to the kinase domain of Xchk1 involves the mecha-
nism that we previously identified for interaction with full-
length Xchk1. We first examined whether a polypeptide con-
taining the CKBD from Claspin could bind to the kinase
domain of Xchk1 (Fig. 2A). For this experiment, we prepared a
fusion protein that contains the MBP and residues 838–920 of
Claspin. We incubated the MBP-CKBD in egg extracts contain-
ing full-length Xchk1-GH, Xchk1-(1–311)-GH, or Xchk1-(1–
265)-GH. We observed that all three Xchk1 polypeptides bound
to the MBP-CKBD with relative efficiencies that were compa-
rable with what we had observed for binding to full-length
Claspin. In a control incubation, MBP alone did not interact
with Xchk1 in this assay. We also asked whether the binding of
Claspin to the kinase domain of Xchk1 requires phosphoryla-
tion on Ser-864 and Ser-895 of Claspin. For this purpose, we
incubated 35S-labeled versions of full-length, wild-type Claspin
or the Claspin-2AG mutant (which contains alanine at posi-
tions 864 and 895) in egg extracts with full-length Xchk1-GH,
Xchk1-(1–265)-GH, or Xchk1-(266–474)-GH in the presence of
pA-pT. As shown in Fig. 2B, full-length Xchk1 and the 1–265
fragment bound to wild-type Claspin but not to the Claspin-
2AG mutant. There was no detectable binding of the 266–474
fragment of Xchk1 to either form of Claspin. Taken together,
these results indicate that the kinase domain of Xchk1 binds to
the CKBD of Claspin in a manner that requires phosphoryla-
tion on Ser-864 and Ser-895.
The Kinase Domain of Xchk1 Contains a Phosphate-binding
Site That Interacts with Phosphorylated Claspin—To define
more precisely how Claspin interacts with the kinase domain,
we attempted to identify positively charged residues (e.g. lysine
and arginine) on the surface of Xchk1 that could potentially
form a phosphate-binding site for the CKB motifs (Figs. 3 and
4). The crystal structure of residues 1–289 from human Chk1
has been solved to atomic resolution (17). A notable feature of
this structure is that it contains a sulfate ion near the catalytic
center of Chk1. There are numerous examples in which sulfate
ions mimic phosphate groups and associate with phosphate-
binding sites in proteins during crystallization procedures (17).
In the case of human Chk1, the sulfate ion resides in a posi-
tively charged cluster of amino acids that contains Lys-54,
Arg-129, Thr-153, and Arg-162 (17).
For illustration, we have diagramed how these residues
could interact with a phosphate group (see Fig. 4). Interest-
ingly, these amino acids all sit in regions of Chk1 that are
generally important for various aspects of catalytic function in
a wide variety of kinases (18, 19). For example, Arg-129 pre-
cedes Asp-130, which is a highly invariant residue in the cat-
alytic loop of protein kinases (Fig. 3A). The corresponding
amino acid in the cyclic AMP-dependent protein kinase (cAPK)
is Asp-166. This residue acts as the base that removes a proton
from the hydroxyl group of the protein kinase substrate. Thr-
153 and Arg-162 lie in a section of Chk1 that corresponds to the
activation loop in various kinases. In the cases of cAPK and
Cdk2, for example, this loop undergoes a phosphorylation that
helps to position the critical aspartate residue in the catalytic
loop. Finally, Lys-54 precedes Glu-55 in the C helix of Chk1.
The equivalent glutamic acid in the C helix of cAPK is Glu-91,
which forms a ion pair with Lys-72 and thereby helps to stabi-
lize interactions between Lys-72 and the  and  phosphates of
ATP. Significantly, the position of the sulfate ion in the crystal
structure of human Chk1 corresponds to the location of the
activating phosphorylation in cAPK and Cdk2 (18, 20). Para-
doxically, however, Chk1 appears not to undergo this type of
activating phosphorylation on its polypeptide chain (17).
We mutated Lys-54, Arg-129, Thr-153, and Arg-162 individ-
ually to alanine in the full-length Xchk1-GH protein. We ob-
served that none of the K54A, R129A, T153A, or R162A mu-
tants could associate stably with Claspin under the conditions
of our binding assay (Fig. 3B). For comparison, we mutated
Lys-53, which is a positively charged residue that lies immedi-
ately adjacent to Lys-54, but does not face the putative phos-
FIG. 2. Binding of Claspin to the kinase domain of Xchk1 in-
volves the CKBD and requires phosphorylation of Claspin on
Ser-864 and Ser-895. A, MBP-CKBD (lanes 1–5) and MBP alone (lane
6) were incubated in egg extracts containing full-length (FL) Xchk1-GH
and the indicated fragments of Xchk1 in the presence of pA-pT and
okadaic acid. The tagged Xchk1 proteins were reisolated, and the sam-
ples were processed for immunoblotting with antibodies against
Claspin (top), MBP (middle), and GST (bottom). Lanes 7 and 8 depict
the initial preparations of MBP-CKBD and MBP, respectively. Lane 9
depicts untreated egg extract (1 l). B, 35S-labeled versions of wild-type
Claspin (lanes 1–3) and Claspin-2AG (lanes 4–6) were incubated in egg
extracts containing full-length Xchk1-GH (lanes 1 and 4), Xchk1-(1–
265)-GH (lanes 2 and 5), and Xchk1-(266–474)-GH (lanes 3 and 6) in
the presence of pA-pT and okadaic acid. The tagged Xchk1 proteins
were reisolated, and binding of the labeled Claspin proteins was as-
sessed after gel electrophoresis and detection with a PhosphorImager.
Lanes 7 and 8 depict the input 35S-labeled proteins. KD, kinase domain;
RD, regulatory domain.
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phate-binding site. We found that the K53A mutant of Xchk1
binds very well to Claspin. We also investigated the Claspin
binding properties of a previously characterized kinase-inac-
tive mutant of Xchk1 (N135A) in which Asn-135 has been
changed to alanine (9). Although Asn-135 also resides in the
catalytic center of Chk1, we observed that the N135A mutant
interacts efficiently with Claspin.
To pursue these observations further, we asked whether
mutants of Xchk1 with alterations in the putative phosphate-
binding site could undergo Xatr-mediated phosphorylation and
activation (Fig. 3B). For this analysis, we examined the phos-
phorylation of Ser-344 on Xchk1 in the absence and presence of
pA-pT. Ser-344 is a major site on Xchk1 for phosphorylation by
Xatr (4). We also assayed the kinase activity of Xchk1 toward a
GST-Cdc25C peptide (8). In the case of the R129A and T153A
mutants, we observed that the checkpoint-dependent phospho-
rylation of Xchk1 on Ser-344 was almost completely abolished.
The R129A mutant displays negligible kinase activity in both
the absence and presence of pA-pT. The T153A mutant pos-
sesses a basal kinase activity similar to that of wild-type
Xchk1. However, the T153A mutant, in contrast to wild-type
Xchk1, does not undergo an increase in activity in response to
pA-pT.
In the case of the K54A mutant, there was reduced but
detectable phosphorylation on Ser-344. Likewise, activation of
the K54A mutant in the presence of pA-pT was diminished
substantially but not abolished. Finally, the R162A mutant
underwent significant phosphorylation on Ser-344, but this
protein did not undergo any increase in activity in the presence
of pA-pT. Thus, for the R162A mutant, there appears to be an
uncoupling between phosphorylation on Ser-344 and elevated
kinase activity. Although we could not detect binding of the
K54A and R162A mutants to Claspin, these mutants may still
be capable of interacting transiently with Claspin. Perhaps this
transient binding would be sufficient to enable some phospho-
rylation of Xchk1 by Xatr. Overall, these experiments indicate
FIG. 3. Effects of point mutations in the kinase domain of Xchk1 on binding to Claspin. A, sequence alignment of the kinase domains
from Xchk1, human Chk1, and mouse cAPK. Lys-53, Lys-54, Arg-129, Asn-135, Thr-153, and Arg-162 of Xchk1 are denoted with asterisks. B,
wild-type Xchk1-GH and various mutant forms of Xchk1 with the indicated alterations in its kinase domain were incubated in egg extracts in the
absence (lanes 1, 3, 5, 7, 9, 11, and 13) or presence (lanes 2, 4, 6, 8, 10, 12, and 14) of pA-pT. All samples contained okadaic acid. The tagged Xchk1
proteins were reisolated. In some cases, the samples were processed for immunoblotting with antibodies against Claspin (top panel), GST (second
panel from top), and Ser(P)-344 of Xchk1 (third panel from top). For the bottom panel, the various reisolated Xchk1 proteins were assayed for kinase
activity toward a GST-Cdc25C peptide. The samples were subjected to gel electrophoresis, and 32P incorporation was detected with a
PhosphorImager.
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that residues in the phosphate-binding site of Xchk1, especially
Arg-129 and Thr-153, are important for the Claspin-dependent
activation of Xchk1.
The C-terminal Regulatory Domain of Xchk1 Requires
Claspin for Its Phosphorylation—Although Claspin binds to
the N-terminal kinase domain of Xchk1, the C-terminal do-
main of Xchk1 also appears to have some role in regulating
the interaction with Claspin. For example, removal of all or
part of the C-terminal regulatory domain from Xchk1 signif-
icantly diminishes binding to Claspin (Fig. 1B). This obser-
vation raises the possibility that the C-terminal domain of
Xchk1 might contain a second binding site for Claspin or
might contribute to the Claspin-binding site in the N-termi-
nal kinase domain. However, we have not been able to ob-
serve stable binding of Claspin to the isolated C-terminal
domain of Xchk1 (see Fig. 1B). To investigate this issue
further, we examined the checkpoint-dependent phosphoryl-
ation of the C-terminal regulatory domain of Xchk1 in the
presence and absence of Claspin (Fig. 5). Consistent with
previous results (21), we observed that a 35S-labeled frag-
ment of Xchk1 containing its C-terminal regulatory domain
(amino acids 266–474) underwent phosphorylation in the
presence of pA-pT and okadaic acid. Significantly, this phos-
phorylation was abolished in extracts from which Claspin
had been removed by immunodepletion. Furthermore, the
checkpoint-dependent phosphorylation of the Xchk1-(266–
474) fragment could be restored by the addition of recombi-
nant His6-Claspin to the Claspin-depleted extracts. The
phosphorylation of the Xchk1-(266–474) fragment still oc-
curred in extracts from which the endogenous full-length
Xchk1 protein had been immunodepleted (not shown). There-
fore, the phosphorylation of the Xchk1-(266–474) fragment
cannot be facilitated by association with endogenous full-
length Xchk1. Overall, these observations suggest that
Claspin also may associate transiently with the C-terminal
regulatory domain of Xchk1.
Claspin Dissociates from the Fully Activated Form of
Xchk1—To characterize the interaction between Claspin and
Xchk1 in further detail, we examined the binding of Claspin to
the activated, highly phosphorylated form of Xchk1. In one set
of experiments, we examined the time course of binding be-
tween Claspin and Xchk1 in egg extracts containing pA-pT and
okadaic acid. As shown in Fig. 6A, the binding of Claspin to
Xchk1 was maximal at around 70 min. In these extracts, the
most highly phosphorylated form of Xchk1 appeared at 100–
130 min. This observation suggests that the fully phosphoryl-
ated form of Xchk1 may dissociate from Claspin.
As another means to examine this issue, we treated egg
extracts with pA-pT and okadaic acid to trigger the phospho-
rylation of Claspin and then added recombinant Xchk1-GH and
EDTA to these extracts (Fig. 6B). As expected, Xchk1 does not
undergo phosphorylation in the presence of EDTA. Nonethe-
less, the hypophosphorylated form of Xchk1 in EDTA-contain-
ing extracts binds very well to the Claspin that had undergone
phosphorylation prior to the addition of EDTA. By comparison,
in the absence of EDTA, we observed considerably less binding
of fully phosphorylated Xchk1 to Claspin. These findings are
also consistent with the concept that hypophosphorylated
Xchk1 binds preferentially to Claspin and then dissociates as a
consequence of phosphorylation and activation.
Previously, we observed that point mutations in the TRF
motif in the C-terminal half of Xchk1 (e.g. T377A) result in a
constitutive 15-fold elevation in kinase activity relative to wild-
type Xchk1 in egg extracts that lack a checkpoint-inducing
DNA signal (16). Therefore, we considered the possibility that
forms of Xchk1 with a mutated TRF motif might display al-
FIG. 5. The C-terminal regulatory domain of Xchk1 depends
upon Claspin for its phosphorylation. A, immunodepletion of
Claspin. Egg extracts were treated with control (lane 1) or anti-Claspin
(lanes 2 and 3) antibodies (9). For lane 3, recombinant His6-Claspin was
added back to the extract at a final concentration of 40 g/ml. Extracts
were immunoblotted with anti-Claspin antibodies. B, the extracts
shown in A were incubated in the absence (lane 1) or presence (lanes
2–4) of pA-pT, as indicated. The extracts also contained an exogenously
added 35S-labeled version of the regulatory domain of Xchk1 (residues
266–474). After a 100-min incubation, the mobility of Xchk1 was mon-
itored by SDS-PAGE and phosphorimaging.
FIG. 4. Illustration of the putative
phosphate-binding site in Chk1. A,
ribbon diagram of residues 1–289 from
human Chk1. The side chains for Lys-54,
Arg-129, Thr-153, and Arg-162, which are
conserved in Xchk1, are indicated. The
putative position of the phosphate group
from a CKB motif of Claspin is illus-
trated. This position corresponds to that
of the sulfate group in the crystal struc-
ture of human Chk1-(1–289) (17). Atomic
coordinates were obtained from the Pro-
tein Data Bank (accession code 1IA8). B,
stick diagram of Lys-54, Arg-129,
Thr-153, and Arg-162 and potential inter-
actions with a phosphate group. Dis-
tances are indicated in angstroms.
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tered Claspin-binding properties. To investigate this matter,
we assayed the Claspin-binding ability of the T377A mutant of
Xchk1 (Fig. 6C). In addition, we examined both the 4AQ mu-
tant of Xchk1, which cannot serve as a substrate for Xatr, and
the combined 4AQ/T377A mutant (4, 16). The 4AQ/T377A mu-
tant displays similarly elevated activity as the T377A single
mutant. We observed that there was negligible binding of the
Xchk1-T377A mutant to Claspin in comparison with wild-type
Xchk1. Moreover, the 4AQ mutant of Xchk1 bound well to
Claspin, whereas the combined 4AQ/T377A mutant displayed
no association with Claspin. Thus, a point mutation in the
C-terminal regulatory domain of Xchk1 that increases its ki-
nase activity in the absence of a checkpoint signal also abol-
ishes binding to Claspin. This abolition of binding occurs even
if Xchk1 cannot undergo phosphorylation of its SQ/TQ motifs
by Xatr. Taken together, all of the above results suggest that
Claspin has a lower affinity for activated Xchk1 than for inac-
tive Xchk1.
DISCUSSION
In this report, we have investigated the features of Xchk1
that allow it to interact with Claspin during a checkpoint
response. Through deletion analysis, we found that the N-
terminal kinase domain of Xchk1 (residues 1–265) can interact
specifically with Claspin in checkpoint-activated extracts. By
constructing various point mutants of Xchk1, we identified four
residues in the kinase domain (e.g. Lys-54, Arg-129, Thr-153,
and Arg-162) that are involved in the interaction with Claspin.
Interestingly, these particular residues comprise a sulfate-
binding site in the crystal structure of human Chk1 (17). This
observation raised the possibility that these amino acids might
normally be involved in coordinating a phosphate group in the
cell. In previous studies, we established that, during a check-
point response, Claspin becomes phosphorylated on two sites
(Ser-864 and Ser-895) that reside in the center of two repeated
peptide sequences in the CKBD of Claspin. As shown here,
phosphorylation of Ser-864 and Ser-895 of the CKBD is neces-
sary for stable binding of Claspin to the isolated kinase domain
of Xchk1. These results suggest that the phosphopeptide motifs
in the CKBD of Claspin interact with the phosphate-binding
pocket in Xchk1. In addition, we have obtained evidence that
the C-terminal domain of Xchk1 (residues 266–474) has a role
in regulation by Claspin.
As an overall model, the activated form of Claspin that has
undergone phosphorylation on Ser-864 and Ser-895 docks with
Xchk1 by means of the phosphate-binding site in its kinase
domain of Xchk1 (Fig. 7). The presence of two CKB motifs in
Claspin might allow as many as two molecules of Xchk1 to dock
with each molecule of Claspin. By examining the structure of
the kinase domain from human Chk1 (17), we inferred that the
spacing between the CKB motifs of Claspin most likely would
enable the binding of two Xchk1 molecules to a Claspin mono-
mer. However, we do not have direct evidence that two mole-
cules of Xchk1 can bind to one Claspin protein. Other possibil-
ities are that Xchk1 may contain a second binding site for the
CKB motifs or that two CKB motifs may allow Claspin to
interact more avidly with a single binding site in the Xchk1
monomer.
Because Claspin binds to Xchk1 and is necessary for the
Xatr-mediated activation of Xchk1, a simple model is that
Claspin somehow recruits Xatr to Xchk1. The docking of the
CKB motifs of Claspin onto the kinase domain of Xchk1 may
facilitate this recruitment and thereby promote the phospho-
rylation of Xchk1 by Xatr. If two Xchk1 molecules can indeed
bind to one molecule of Claspin, these interactions might also
facilitate intermolecular autophosphorylation of Xchk1. Once
Xchk1 becomes activated, our results suggest that Xchk1 would
dissociate from Claspin. As described in this paper, the hy-
pophosphorylated, low-activity form of Xchk1 binds better to
Claspin than the hyperphosphorylated, activated version of
Xchk1. This dissociation of activated Xchk1 would allow
Claspin to recruit more Xchk1 for additional rounds of activa-
tion. By analogy, it has been shown in budding yeast that the
hypophosphorylated, inactive form Rad53 interacts best with
Rad9, whereas the activated, hyperphosphorylated version of
Rad53 dissociates from Rad9 (22).
The interaction between Claspin and Xchk1 bears some sim-
ilarities with the glycogen synthase kinase-3 system (23).
FIG. 6. Claspin dissociates from the fully activated form of
Xchk1. A, time course of interaction between Claspin and Xchk1 in
checkpoint-activated extracts. Recombinant Xchk1-GH was incubated
in egg extracts in the absence or presence of pA-pT. At the indicated
times, the tagged Xchk1 was reisolated, and binding of Claspin was
determined by immunoblotting with anti-Claspin antibodies (top).
Xchk1-GH was detected with anti-GST antibodies (bottom). B, Claspin
interacts strongly with the hypophosphorylated form of Xchk1. At time
0, egg extracts (100 l) were incubated with either pA (lane 1) or pA-pT
plus okadaic acid (lanes 2 and 3) for 90 min at room temperature. At
this time, 200 l of a solution containing 20 mM EDTA, 0.1% CHAPS,
2.5 mM EGTA, and 20 mM -glycerol phosphate in HEPES-buffered
saline solution was added to the samples (lanes 1–3). Xchk1-GH was
added either at time 0 (lane 3) to allow its modification in the extract or
after addition of the EDTA-containing buffer (lanes 1 and 2) to prevent
its phosphorylation. Thereafter, Xchk1-GH was re-isolated through a
60-min incubation at 4 °C with glutathione-agarose beads. The bead
preparations were subjected to SDS-PAGE and probed by immunoblot-
ting with anti-Claspin (top) and anti-GST antibodies (bottom). Lane 4
depicts untreated egg extract. C, the constitutively activated, hyper-
phosphorylated T377A mutant of Xchk1 does not bind well to Claspin.
His6-GST (lane 1), wild-type (WT), full-length Xchk1-GH (lane 2), and
various point mutants of Xchk1-GH (N135A, 4AQ, 4AQ/T377A, and
T377A) (lanes 3–6) were incubated in egg extracts containing pA-pT
and okadaic acid. The tagged proteins were reisolated, and binding of
Claspin was determined by immunoblotting with anti-Claspin antibod-
ies. Immunoblotting with anti-GST antibodies indicated that recovery
of His6-GST and the tagged Xchk1 proteins was similar for all samples
(not shown).
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Glycogen synthase kinase-3 utilizes a phosphate-binding site
in its kinase domain to dock with prospective substrates that
have already received a priming phosphorylation. In humans,
for example, the priming phosphate group on a substrate in-
teracts with glycogen synthase kinase-3 by means of Arg-96,
Arg-180, and Lys-205 in the kinase domain. The positions of
these residues correspond to those of Lys-54, Arg-129, and
Thr-153 in Xchk1, respectively. Thus, both Xchk1 and glycogen
synthase kinase-3 employ a phosphate-interacting pocket in
their kinase domains to recognize other molecules. However, a
significant difference between the two systems is that Claspin
is an upstream regulator and not a substrate of Xchk1. In this
regard, we have not been able to observe in vitro phosphoryl-
ation of Claspin by Xchk1.2
An interesting question is why Claspin would dock with
Xchk1 near its catalytic center. A significant observation from
structural studies is that the kinase domain of human Chk1
(residues 1–289) adopts an open lobe conformation with a slight
misalignment of residues that are critical for catalysis (17). The
structure of the 1–289 fragment from human Chk1 does not
vary with and without a bound sulfate ion (17), suggesting that
a phosphate group alone at this location would not significantly
affect the conformation of the kinase domain. The consensus
sequence for the CKB motif (EXXXLCSGXF) is highly con-
served in metazoan Claspin molecules. It is possible that resi-
dues in addition to the phosphoserine in this motif might in-
teract with side chains of Xchk1 in the vicinity of the
phosphate-binding site. It is conceivable that such interactions
might alter the conformation of Xchk1 so that it could achieve
its most active state. Alternatively, this interaction may simply
allow docking between Claspin and Xchk1.
In conclusion, we have found that Claspin interacts with
Xchk1 by means of a phosphate-binding site in its kinase do-
main. This step is important for the proper activation of Xchk1
during a checkpoint response.
Acknowledgments—We are very grateful to Jun-yong Choe for assist-
ance with the structural diagrams of Chk1 in Fig. 4. We thank the
members of our laboratory for helpful comments on the manuscript.
REFERENCES
1. Melo, J., and Toczyski, D. (2002) Curr. Opin. Cell Biol. 14, 237–245
2. Osborn, A. J., Elledge, S. J., and Zou, L. (2002) Trends Cell Biol. 12, 509–516
3. Morgan, D. O. (1997) Annu. Rev. Cell Dev. Biol. 13, 261–291
4. Guo, Z., Kumagai, A., Wang, S. X., and Dunphy, W. G. (2000) Genes Dev. 14,
2745–2756
5. Hekmat-Nejad, M., You, Z., Yee, M., Newport, J. W., and Cimprich, K. A.
(2000) Curr. Biol. 10, 1565–1573
6. Liu, Q., Guntuku, S., Cui, X. S., Matsuoka, S., Cortez, D., Tamai, K., Luo, G.,
Carattini-Rivera, S., DeMayo, F., Bradley, A., Donehower, L. A., and
Elledge, S. J. (2000) Genes Dev. 14, 1448–1459
7. Zhao, H., and Piwnica-Worms, H. (2001) Mol. Cell. Biol. 21, 4129–4139
8. Kumagai, A., Guo, Z., Emami, K. H., Wang, S. X., and Dunphy, W. G. (1998)
J. Cell Biol. 142, 1559–1569
9. Kumagai, A., and Dunphy, W. G. (2000) Mol. Cell 6, 839–849
10. Alcasabas, A. A., Osborn, A. J., Bachant, J., Hu, F., Werler, P. J., Bousset, K.,
Furuya, K., Diffley, J. F., Carr, A. M., and Elledge, S. J. (2001) Nat. Cell
Biol. 3, 958–965
11. Tanaka, K., and Russell, P. (2001) Nat. Cell Biol. 3, 966–972
12. Chini, C. C., and Chen, J. (2003) J. Biol. Chem. 278, 30057–30062
13. Lee, J., Kumagai, A., and Dunphy, W. G. (2003) Mol. Cell 11, 329–340
14. Osborn, A. J., and Elledge, S. J. (2003) Genes Dev. 17, 1755–1767
15. Kumagai, A., and Dunphy, W. G. (2003) Nat. Cell Biol. 5, 161–165
16. Wang, S. X., and Dunphy, W. G. (2000) FEBS Lett. 487, 277–281
17. Chen, P., Luo, C., Deng, Y., Ryan, K., Register, J., Margosiak, S., Tempczyk-
Russell, A., Nguyen, B., Myers, P., Lundgren, K., Kan, C. C., and O’Connor,
P. M. (2000) Cell 100, 681–692
18. Johnson, L. N., Noble, M. E., and Owen, D. J. (1996) Cell 85, 149–158
19. Huse, M., and Kuriyan, J. (2002) Cell 109, 275–282
20. Morgan, D. O., and De Bondt, H. L. (1994) Curr. Opin. Cell Biol. 6, 239–246
21. Michael, W. M., Ott, R., Fanning, E., and Newport, J. (2000) Science 289,
2133–2137
22. Gilbert, C. S., Green, C. M., and Lowndes, N. F. (2001) Mol. Cell 8, 129–136
23. Doble, B. W., and Woodgett, J. R. (2003) J. Cell Sci. 116, 1175–1186
2 S.-Y. Jeong, A. Kumagai, J. Lee, and W. G. Dunphy, unpublished
data.
FIG. 7. Model for the interaction of Xchk1 with Claspin. Claspin, which has been phosphorylated on its two CKB motifs, recruits one or
more molecules of Xchk1. Phosphorylation of Xchk1 on its SQ/TQ motifs by Xatr and autophosphorylation lead to the activation of Xchk1. The fully
phosphorylated form of Xchk1 dissociates from Claspin.
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